The University of Notre Dame Australia

ResearchOnline@ND
Physiotherapy Papers and Journal Articles

School of Physiotherapy

2021

Are you translating research into clinical practice? What to think about
when it does not seem to be working
Myles Calder Murphy
The University of Notre Dame Australia, myles.murphy@nd.edu.au

William Gibson
The University of Notre Dame Australia, william.gibson@nd.edu.au

G. Lorimer Moseley
Ebonie Kendra Rio

Follow this and additional works at: https://researchonline.nd.edu.au/physiotherapy_article
Part of the Medicine and Health Sciences Commons
This other contribution to a refereed journal was originally published as:
Murphy, M. C., Gibson, W., Moseley, G., & Rio, E. K. (2021). Are you translating research into clinical practice? What to think about
when it does not seem to be working. British Journal of Sports Medicine, 55 (12), 652-653.
Original other contribution to a refereed journal available here:
10.1136/bjsports-2020-102369

This other contribution to a refereed journal is posted on
ResearchOnline@ND at https://researchonline.nd.edu.au/
physiotherapy_article/174. For more information, please contact
researchonline@nd.edu.au.

©2021. This manuscript version is made available under the CC-BY-NC 4.0 International
license https://creativecommons.org/licenses/by-nc/4.0/

This is the accepted manuscript version of an article published as:
Murphy, M.C., Gibson, W., Moseley, G.L., & Rio, E.K. (2021) Are you translating research into
clinical practice? What to think about when it does not seem to be working. British Journal
of Sports Medicine, 55(12) https://doi.org/10.1136/bjsports-2020-102369

This article has been published in final form at
https://doi.org/10.1136/bjsports-2020-102369

Research translation? What to think about when it’s not working
Myles Murphy 1,2
William Gibson 1
G. Lorimer Moseley3
Ebonie Rio 4

Affiliations
1

School of Physiotherapy, The University of Notre Dame Australia, Fremantle, WA, Australia

2

SportsMed Subiaco, St John of God Health Care, Subiaco, WA, Australia

3

IIMPACT in Health, University of South Australia, Adelaide, South Australia, Australia

4.

La Trobe Sports and Exercise Medicine Research Centre, La Trobe University, Bundoora, VIC,

Australia

Corresponding author

Corresponding Author: Myles Murphy, School of Physiotherapy, University of Notre Dame Australia,
19 Mouat Street (PO Box 1225), Fremantle, Western Australia, 6959, Australia.

The word count for the text is 841 words (excluding tables and figures), there are 8 references, there
are 0 tables, 0 figures and 1 appendix.

Introduction

The value of clinical research can be lost in translation and implementation. One often overlooked
issue concerns how easily clinicians can determine whether their patient is similar to research
participants and, ipso facto, whether their treatment will have the same effects as those reported in
a research study. This editorial presents five questions and clinical tips for clinicians facing these
issues.

Who are the research participants?

The characteristics of a research study’s participants can be considered their ‘clinical phenotype’.
The field dedicated to more precisely matching treatments to clinical phenotypes is ‘precision
medicine’.1 Defining clinical phenotypes remains a great challenge in musculoskeletal research
because a gold standard diagnostic test is commonly absent. For example, the single leg decline
squat is provocative for anterior knee pain but is not diagnostic for patellar tendinopathy.2 Even
where agreement exists as to a patient group having the same condition (e.g. rotator cuff
tendinopathy), different clinical phenotypes (e.g. positive versus negative empty can test) within
that group represent heterogenous populations, with potentially variable responses to
interventions.

Clinical tip: Don’t rely on the title or abstract of a paper. Review the methods section for details on
more precise clinical phenotypes (or not), including how the condition was diagnosed and other
features such as physical activity, education, cognitive or socioeconomic characteristics.3 Does your
patient match the clinical phenotype(s) in the study?

Are those with comorbidities excluded?

Research studies usually involve stricter inclusion criteria than clinical practice does. This may mean
your patient will not nicely match the research cohort. For example, the presence of comorbid

conditions such as depression or other areas of pain (Appendix A), often means exclusion from
research studies because these conditions can confound results (via known - e.g. impaired
descending inhibition - and unknown mechanisms), necessitating bigger samples and more
resources,4 but such comorbidities are common in clinical presentations.

Clinical tip: Clarify whether your patient would satisfy the inclusion and exclusion criteria of the
study. Consider comorbidities when planning and interpreting your intervention.

What non-specific treatment effects could be at play?

Non-specific treatment effects are those that occur in response to an intervention but are not
mediated by the intended active, or unique, component of the intervention.5 Non-specific effects
become more likely as the outcome of interest moves towards clinically relevant metrics such as
pain, quality of life and return to sport or work. For example, although pain modulation with exercise
is often attributed to injury healing or aggravation, which reflects a biomedical tissue-focussed
interpretation, there are other aspects of exercise that are also likely to change pain.5 Relevant here
are contemporary understandings of pain as providing a protective buffer for tissues (rather than a
‘read out of tissue state’), the size of which depends on complex and multifactorial processes across
bio-, psycho- and social domains.5,6

Clinical tip: Consider all possible mechanisms by which a study’s treatment could cause a change in
outcome, not just the mechanism mentioned in the title.

Does the authors’ interpretation match their study design?

We recently conducted a case-series investigating the effect of an isometric squat in-season training
program for jumping and landing athletes with patellar tendinopathy.7 We observed a decrease in
pain over the 4-week intervention period. Our design allowed us to conclude that pain decreased
during the course of the intervention, but not that pain decreased because of the intervention or any

part thereof. In addition to the passing of time, many non-specific effects may have been at play
(e.g. expectations of effect, different training structure and timing, increased care). The important
clinical consideration of such studies is that the specificity with which results can be explained by
mechanisms is limited by the extent to which the design isolates those mechanisms from others.
That is, to gain the study’s effect with your patient may require replication of the intended active
component (isometric squats in the above example) and everything else not controlled for in the
study.

Clinical tip: Look for potential non-specific treatment mechanisms that can be replicated or
estimated, for example by providing positive, accurate messaging and referring the patient to the
published research.

Are too many assessments spoiling your result?

The sensitivity of pain processing can be rapidly and substantially modified by a wide range of
factors from across the biopsychosocial spectrum.8 It is important to remember the potential effect
of multiple assessments, especially pain provocation tests and the order in which they are
conducted. For example: imagine one performs a pain provocation test, then assesses pain; then
assesses mechanical sensitivity via palpation; then implements an intervention; then reperforms the
provocation test, palpation and finally reassess pain. Any or all the assessments could modify
sensitivity, clouding the value of the final pain reassessment. Multiple assessments can both increase
or decrease an apparent treatment effect, just as repeated pain provocation tests can increase or
decrease pain, dependent on myriad of intra- and inter-individual factors.

Clinical tip: Understand how assessments (e.g. palpation of the painful structure) can influence
peripheral and central sensitivity. Select a single assessment most likely to detect the effect you
intend to induce.
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